Related by context. Frequent words. (Click for all words.) 70 Prescribing Information 65 Full Prescribing Information 65 TYGACIL 63 NOXAFIL 63 Boxed Warning 63 FIRAZYR 63 QNEXA 62 FDA Accepts 62 Pirfenidone 62 Marketing Authorization 61 Mutual Recognition Procedure 61 Positive Opinion 61 CHMP opinion 61 Marketing Authorization Application 61 Plenaxis R 60 Rebif ® 60 alvimopan 60 TYKERB 60 Pivotal Phase III 60 Adalimumab 60 Diabetologia 60 Tracleer ® 60 Ilaris 60 THELIN 60 Cimzia R 59 Dasatinib 59 Benign Prostatic Hyperplasia 59 ROTATEQ 59 European Medicines Evaluation 59 daptomycin 59 Torisel 59 Icatibant 59 Phase III Clinical Trial 59 Avastin bevacizumab 59 Amrubicin 59 full Prescribing Information 59 roflumilast 59 orphan designation 59 Complete Response 59 Aclasta 58 Sensipar 58 Extavia 58 TORISEL 58 Azilect ® 58 Taxotere ® 58 Arixtra 58 IRESSA 58 Cimzia ® 58 PROMACTA 57 orphan medicinal product 57 Panzem R 57 Cladribine 57 Pulmonary Arterial Hypertension 57 LIALDA 57 Hycamtin 57 Generic Version 57 Eloxatin R 57 Clinical Trial Results 57 Position Statement 57 Marketing Authorization Application MAA 57 NCCN Guidelines 57 Telavancin 57 Allergic Rhinitis 57 Protopic 57 FOSRENOL R 57 romiplostim 57 somatropin 57 Pegintron 57 Pivotal Trial 57 elotuzumab 57 Multaq R 57 lumiracoxib 57 Maraviroc 57 silodosin 56 Drug Interactions 56 SEROQUEL XR 56 R sorafenib tablets 56 Medication Guide 56 Drug Candidate 56 SABCS 56 FOSRENOL 56 FDA approvable letter 56 Combidex 56 Focalin XR 56 Toctino ® 56 REVLIMID R 56 Medicinal Products EMEA 56 Angiox 56 Orphan Medicinal Product 56 REMICADE ® 56 Monotherapy 56 tocilizumab 56 REPLAGAL 56 Inc Therapeutic Competitors 56 Toctino R 56 Vfend 56 J Am Coll 56 ezogabine 56 Presents Positive 56 AVANDIA 56 Vandetanib